Paolo Maver
Policlinico S.Orsola-Malpighi(IT)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer(1988)32 cited
- → A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer(1996)23 cited
- → Immunotherapy of metastatic kidney cancer(2001)20 cited
- → Chemotherapy with Cisplatin, Epirubicin, Methotrexate in the Treatment of Locally Advanced or Metastatic Transitional Cell Cancer of the Bladder (TCC)(1992)5 cited
- → Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): A preliminary report(1996)4 cited
- → Low Dose Intermittent 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) in Poor Risk Patients with Advanced Transitional Cell Bladder Cancer: a Pilot Study(1989)2 cited
- → A New Regimen of Cisplatin, Epirubicin and Methotrexate (PEM-3) as Primary Chemothfrapy for Locally Advanced Bladder Cancer(1996)2 cited
- → The Value of Propionhydroxamic Acid in the Prevention and Therapy of Infection-Induced Stones(2015)1 cited
- [Chemoprophylaxis of superficial tumors of the bladder with bleomycin].(1986)
- [Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience].(1988)